FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:1388-1389 May 8, 1997 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Rose, P. G.

To the Editor: In his excellent review of endometrial carcinoma (Aug. 29 issue),¹ Dr. Rose correctly describes the important etiologic role of unopposed estrogen, pointing out that "excessive estrogen is associated with most of the risk factors that have been linked to endometrial carcinoma." However, in the section on screening, Dr. Rose fails to discuss a plasma or saliva assay for estrogen and progesterone. It is the ratio of estrogen to progesterone that determines what level of estrogen is excessive. Prevention being better than early diagnosis of an existing carcinoma, one would think that testing for both hormones should be . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.